Cholesterol synthesis, cholesterol absorption, and mortality in hemodialysis patients.

Détails

Ressource 1Demande d'une copie Sous embargo indéterminé.
Etat: Public
Version: de l'auteur
ID Serval
serval:BIB_58F16C6BB5C0
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Cholesterol synthesis, cholesterol absorption, and mortality in hemodialysis patients.
Périodique
Clinical Journal of the American Society of Nephrology
Auteur(s)
Rogacev K.S., Pinsdorf T., Weingärtner O., Gerhart M.K., Welzel E., van Bentum K., Popp J., Menzner A., Fliser D., Lütjohann D., Heine G.H.
ISSN
1555-905X (Electronic)
ISSN-L
1555-9041
Statut éditorial
Publié
Date de publication
2012
Peer-reviewed
Oui
Volume
7
Numéro
6
Pages
943-948
Langue
anglais
Notes
Publication types: Journal Article ; Multicenter Study
Résumé
BACKGROUND AND OBJECTIVES: Recent clinical trials on cholesterol-lowering in patients with CKD yielded conflicting results, which might have resulted from different treatment strategies. Serum cholesterol levels are determined by endogenous synthesis and intestinal absorption, which are differentially influenced by various classes of cholesterol-lowering agents. Assessing markers of cholesterol metabolism has thus been proposed for guidance of lipid-lowering therapy. This study analyzed surrogate markers of cholesterol absorption and synthesis in hemodialysis (HD) patients.
DESIGN, SETTING, PARTICIPANTS, & MEASUREMENTS: In 113 HD patients, lathosterol was measured as a marker of cholesterol synthesis and cholestanol was measured as a marker of cholesterol absorption via gas chromatography. Controls were 229 healthy persons. Overall survival in HD patients was recorded over 3.4-year follow-up.
RESULTS: Compared with controls, HD patients had lower lathosterol and higher cholestanol levels (P<0.001 for both). During follow-up, 58 patients died; higher cholestanol (indicating higher cholesterol absorption) predicted poor outcome among HD patients in multivariate Cox regression analysis after adjustment for potential confounders (hazard ratio for cholestanol above median, 2.24 [95% confidence interval (CI), 1.29-3.89]; P=0.004), whereas lower lathosterol (indicating lower cholesterol synthesis) did not (hazard ratio for lathosterol below median, 1.43 [95% CI, 0.81-2.50]; P=0.22).
CONCLUSIONS: This analysis of markers of cholesterol metabolism characterizes HD patients as cholesterol absorbers. In longitudinal analysis, higher levels of cholestanol were associated with all-cause mortality.
Mots-clé
Aged, Aged, 80 and over, Biological Markers/blood, Case-Control Studies, Cholestanol/blood, Cholesterol/biosynthesis, Cholesterol/blood, Chromatography, Gas, Chronic Disease, Female, Follow-Up Studies, Germany, Humans, Intestinal Absorption, Kaplan-Meier Estimate, Kidney Diseases/metabolism, Kidney Diseases/mortality, Male, Middle Aged, Multivariate Analysis, Proportional Hazards Models, Renal Dialysis/adverse effects, Renal Dialysis/mortality, Risk Assessment, Risk Factors, Time Factors, Treatment Outcome
Pubmed
Open Access
Oui
Création de la notice
02/04/2012 8:30
Dernière modification de la notice
20/08/2019 14:12
Données d'usage